Anti-UBE2A monoclonal antibody
Pre-made anti-UBE2A monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to UBE2A/UBE2A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP2794-Ab-1/ GM-Tg-hg-IP2794-Ab-2 | Anti-Human UBE2A monoclonal antibody | Human |
GM-Tg-rg-IP2794-Ab-1/ GM-Tg-rg-IP2794-Ab-2 | Anti-Rat UBE2A monoclonal antibody | Rat |
GM-Tg-mg-IP2794-Ab-1/ GM-Tg-mg-IP2794-Ab-2 | Anti-Mouse UBE2A monoclonal antibody | Mouse |
GM-Tg-cynog-IP2794-Ab-1/ GM-Tg-cynog-IP2794-Ab-2 | Anti-Cynomolgus/ Rhesus macaque UBE2A monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP2794-Ab-1/ GM-Tg-felg-IP2794-Ab-2 | Anti-Feline UBE2A monoclonal antibody | Feline |
GM-Tg-cang-IP2794-Ab-1/ GM-Tg-cang-IP2794-Ab-2 | Anti-Canine UBE2A monoclonal antibody | Canine |
GM-Tg-bovg-IP2794-Ab-1/ GM-Tg-bovg-IP2794-Ab-2 | Anti-Bovine UBE2A monoclonal antibody | Bovine |
GM-Tg-equg-IP2794-Ab-1/ GM-Tg-equg-IP2794-Ab-2 | Anti-Equine UBE2A monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP2794-Ab-1/ GM-Tg-hg-IP2794-Ab-2; GM-Tg-rg-IP2794-Ab-1/ GM-Tg-rg-IP2794-Ab-2; GM-Tg-mg-IP2794-Ab-1/ GM-Tg-mg-IP2794-Ab-2; GM-Tg-cynog-IP2794-Ab-1/ GM-Tg-cynog-IP2794-Ab-2; GM-Tg-felg-IP2794-Ab-1/ GM-Tg-felg-IP2794-Ab-2; GM-Tg-cang-IP2794-Ab-1/ GM-Tg-cang-IP2794-Ab-2; GM-Tg-bovg-IP2794-Ab-1/ GM-Tg-bovg-IP2794-Ab-2; GM-Tg-equg-IP2794-Ab-1/ GM-Tg-equg-IP2794-Ab-2 |
Products Name | Anti-UBE2A monoclonal antibody |
Format | mab |
Target Name | UBE2A |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-UBE2A monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP2794-Ag-1 | Recombinant multi-species UBE2A/ HHR6A/ MRXS30 protein |
Target information
Target ID | GM-IP2794 |
Target Name | UBE2A |
Gene ID | 7319,22209,298317,693716,492095,101083326,282107,100058679 |
Gene Symbol and Synonyms | BHR6A,HHR6A,HR6A,Mhr6a,MRXS30,MRXSN,RAD6A,UBC2,UBE2A |
Uniprot Accession | P49459 |
Uniprot Entry Name | UBE2A_HUMAN |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000077721 |
Target Classification | N/A |
The target: UBE2A, gene name: UBE2A, also named as HHR6A, MRXS30, MRXSN, RAD6A, UBC2. The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, ubiquitin-conjugating enzymes, and ubiquitin-protein ligases. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. This enzyme is required for post-replicative DNA damage repair, and may play a role in transcriptional regulation. Mutations in this gene are associated with cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.